期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
His bundle pacing versus left bundle branch pacing on ventricular function in atrial fibrillation patients referred for pacing:a prospective crossover comparison 被引量:2
1
作者 Yang YE Bo GAO +21 位作者 Yuan LV Tian-Tian XU Si-Si ZHANG Xiao-Li LU Ying YANG dong-mei jiang Yi-Wen PAN Xia SHENG Bei WANG Yan-Kai MAO Zu-Wen ZHANG Shi-Quan CHEN Jie-Fang ZHANG Li WANG jiang-Fen jiang Ya-Xun SUN Yan MA Fei-Ling WANG Min WANG Hong HE Chen-Yang jiang Guo-Sheng FU 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2023年第1期51-60,共10页
BACKGROUND His bundle pacing(HBP)and left bundle branch pacing(LBBP)both provide physiologic pacing which maintain left ventricular synchrony.They both improve heart failure(HF)symptoms in atrial fibrillation(AF)patie... BACKGROUND His bundle pacing(HBP)and left bundle branch pacing(LBBP)both provide physiologic pacing which maintain left ventricular synchrony.They both improve heart failure(HF)symptoms in atrial fibrillation(AF)patients.We aimed to assess the intra-patient comparison of ventricular function and remodeling as well as leads parameters corresponding to two pacing modalities in AF patients referred for pacing in intermediate term.METHODS Uncontrolled tachycardia AF patients with both leads implantation successfully were randomized to either modality.Echocardiographic measurements,New York Heart Association(NYHA)classification,quality-of-life assessments and leads parameters were obtained at baseline and at each 6-month follow up.Left ventricular function including the left ventricular endosystolic volume(LVESV),left ventricular ejection fraction(LVEF)and right ventricular(RV)function quantified by tricuspid annular plane systolic excursion(TAPSE)were all assessed.RESULTS Consecutively twenty-eight patients implanted with both HBP and LBBP leads successfully were enrolled(69.1±8.1 years,53.6% male,LVEF 59.2%±13.7%).The LVESV was improved by both pacing modalities in all patients(n=23)and the LVEF was improved in patients with baseline LVEF at less than 50%(n=6).The TAPSE was improved by HBP but not LBBP(n=23).CONCLUSION In this crossover comparison between HBP and LBBP,LBBP was found to have an equivalent effect on LV function and remodeling but better and more stable parameters in AF patients with uncontrolled ventricular rates referred for atrioventricular node(AVN)ablation.HBP could be preferred in patients with reduced TAPSE at baseline rather than LBBP. 展开更多
关键词 VENTRICULAR PATIENTS BUNDLE
下载PDF
Human umbilical cord blood stem cells and brainderived neurotrophic factor for optic nerve injury: a biomechanical evaluation 被引量:13
2
作者 Zhong-jun Zhang Ya-jun Li +5 位作者 Xiao-guang Liu Feng-xiao Huang Tie-jun Liu dong-mei jiang Xue-man Lv Min Luo 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第7期1134-1138,共5页
Treatment for optic nerve injury by brain-derived neurotrophic factor or the transplantation of human umbilical cord blood stem cells has gained progress, but analysis by biomechanical indicators is rare. Rabbit model... Treatment for optic nerve injury by brain-derived neurotrophic factor or the transplantation of human umbilical cord blood stem cells has gained progress, but analysis by biomechanical indicators is rare. Rabbit models of optic nerve injury were established by a clamp. At 7 days after injury, the vitreous body received a one-time injection of 50 μg brain-derived neurotrophic factor or 1 × 10^6 human umbilical cord blood stem cells. After 30 days, the maximum load, maximum stress, maximum strain, elastic limit load, elastic limit stress, and elastic limit strain had clearly improved in rabbit models of optical nerve injury after treatment with brain-derived neurotrophic factor or human umbilical cord blood stem cells. The damage to the ultrastructure of the optic nerve had also been reduced. These findings suggest that human umbilical cord blood stem cells and brain-derived neurotrophic factor effectively repair the injured optical nerve, improve biomechanical properties, and contribute to the recovery after injury. 展开更多
关键词 nerve regeneration optic nerve injury human umbilical cord blood stem cells brain-derived neurotrophic factor biomechanical properties neural regeneration
下载PDF
Gemcitabine and cisplatin combined with the Chinese herbal medicine compound Fuzhenggubenfang improve quality of life and progression-free survival in patients with advanced non-small cell lung cancer 被引量:3
3
作者 dong-mei jiang Feng-Wei Wang +3 位作者 Li-Juan Zhang Long Zhang Tai Zhang Wen-Hua Zhang 《Traditional Medicine Research》 2018年第1期40-51,共12页
目的:评估化疗联合扶正固本方治疗晚期非小细胞肺癌的作用.方法:2013年10月至2016年7月共收治符合条件的患者84例.随机分配到接受化疗的对照组和化疗联合扶正固本方的实验组.研究的主要终点指标是生活质量(QOL)和无进展生存期(PFS... 目的:评估化疗联合扶正固本方治疗晚期非小细胞肺癌的作用.方法:2013年10月至2016年7月共收治符合条件的患者84例.随机分配到接受化疗的对照组和化疗联合扶正固本方的实验组.研究的主要终点指标是生活质量(QOL)和无进展生存期(PFS).次要终点指标是肿瘤反应率,化疗相关毒性,出组率,QOL和PFS临床病理因素的单因素和多因素分析.结果:实验组较对照组总体生活质量包括躯体功能、角色功能、情绪功能、认知功能、社会功能均有显著改善(均P〈0.001),疲乏、恶心或呕吐、失眠、食欲减退、便秘亦显著改善(均P〈0.001).实验组较对照组获得更好的PFS且有显著性差异(P=0.032).两组肿瘤反应率无显著性差异.扶正固本方明显减少化疗引起的贫血,中性粒细胞减少、恶心、呕吐(均P〈0.001),且只有轻微的副作用.本研究中影响QOL的临床病理因素包括:中药(P〈0.001)、体力状态评分(P=0.027)、临床分期(P=0.009)、性别(P=0.044).影响PFS的临床病理因素包括中药(P=0.043)和既往化疗次数(P=0.003).结论:扶正固本方可通过改善晚期非小细胞肺癌患者QOL,改善患者对治疗的治疗依从性,减轻化疗相关毒副反应,从而改善PFS,提高生存率,是晚期非小细胞肺癌治疗期间可选择的辅助用药. 展开更多
关键词 非小细胞肺癌 中药 随机对照临床试验 辅助治疗
下载PDF
Chinese herbal protocol anti-fibrosis 1 improves radiation induced fibrosis and its related dysfunctions
4
作者 dong-mei jiang Ying-Ying Jin +7 位作者 Liu-Hua Long Li-Jue Zhang Si-Hai Tan Pei-Pei Song Long Zhang Tai Zhang Wen-Hua Zhang Feng-Wei Wang 《TMR Integrative Medicine》 2019年第5期1-9,共9页
Objective: Radiotherapy is the main modality for treatment of malignancies, but radiation fibrosis is a severe side effect of radiotherapy which may cause severe dysfunction of patients. We design a new tr aditional C... Objective: Radiotherapy is the main modality for treatment of malignancies, but radiation fibrosis is a severe side effect of radiotherapy which may cause severe dysfunction of patients. We design a new tr aditional Chinese her bal pr otocol, which is named as Anti-fibrosis 1, and use it in patients with severe radiation fibrosis. Methods: From Feb 2013 to Feb 2014, 23 patients with severe radiation fibrosis and apparent dysfunction were treated with anti-fib rosis 1. The re were 7 pa ti ents with nasopharyngeal car cinoma, 7 with oral cavity and oral pharyngeal carcinoma, 2 with pharyngeal carcinoma, 2 with breast carcinoma, 2 with esophageal carcinoma and 3 patients with pelvic malignancies. All patients received radiothe rapy at least 0.5-8 years ago, and 22 pa ti ents with complete response, but all patients suffered with severe radiation fibrosis. The radiation dosage was among 50-74Gy/25-37f/35-70d. Patients status of fibrosis and recovery of tissue and organ were evaluated after 0.5, 1.5 and 3 months of herbal treatment. Results: 22 of 23 patients were head and neck car cinoma, 20 pati ents had got par tial r elief afte r 15 days medication with anti-fib rosis 1, nea rly all pa ti ents had got appa rent r elief afte r 1.5 month of medication. But, there was no apparent difference between 1.5 month and 3 months group. There were no apparent side effects after the herbal treatment. Conclusions: The traditional Chinese herbal protocol anti-fibrosis 1 is an effective and safe modality for radiation fibrosis. And the apparent effect occurred after 1.5 month of herbal medication. 展开更多
关键词 Radia tion fibr osis TCM SIDE effects Cancer
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部